Based on reported financial statement history.
Over longer horizons, Revenue CAGR averages -33.21% over 3 years; the trailing 12 months came in at -61.61%.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Revenue CAGR measures how the company's top-line revenue has grown over time. Consistent revenue growth is a key indicator of business expansion and market share gains.
Ping An Biomedical Co., Ltd. (PASW)
Reported quarterly revenue; no daily interpolation.
Limited quarterly history available
Revenue needs at least three reported quarters before a meaningful chart is shown.
| Year | Start Revenue | End Revenue | Change | % Change |
|---|---|---|---|---|
| 2025 | $12.48M | $4.80M | −$7.69M | -61.58% |
| 2024 | $11.31M | $12.48M | +$1.18M | +10.41% |
| 2023 | $16.10M | $11.31M | −$4.79M | -29.77% |
| 2022 | $15.43M | $16.10M | +$663.67K | +4.30% |
